Viewing Study NCT03059732


Ignite Creation Date: 2025-12-24 @ 9:35 PM
Ignite Modification Date: 2025-12-31 @ 2:05 AM
Study NCT ID: NCT03059732
Status: COMPLETED
Last Update Posted: 2019-02-27
First Post: 2017-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Factors Associated With High Mortality of Gastric Adenocarcinoma in Thailand Versus Japan
Sponsor: King Chulalongkorn Memorial Hospital
Organization:

Study Overview

Official Title: Factors Associated With High Mortality of Gastric Adenocarcinoma in Thailand Versus Japan
Status: COMPLETED
Status Verified Date: 2019-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The differences in patient's clinicopathological characteristic between high and low prevalence of gastric cancer region should be further examined to elucidate factors that associate with poor survival rate of patients with gastric cancer. Therefore, this study aimed to evaluate characteristics of patients with gastric adenocarcinoma and factors associated with different outcome in Thailand and Japan to find a clue to improve patients' survival in low prevalence country such as Thailand.

This is a retrospective cohort study. It was conducted at King Chulalongkorn Memorial Hospital, Thailand and Osaka Medical Center for Cancer and Cardiovascular Disease, Japan. Eligible cases were selected by using standardized search protocols: formal computer searches of all patients seen at out-patient clinic and/or hospitalized for gastric cancer between 2010 and 2014.Two physicians, who were informed the definition of each variable, individually reviewed chart of patients.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: